Skye Bioscience SKYE
NASDAQ SKYE
$1.07 -0.03 (-2.29%)
At close: Nov 16, 2026 · 4:00 PM EST

Skye Bioscience (SKYE) Net Long-Term Debt Issued (Repaid) (2013 - 2026)

Updated

Skye Bioscience's Non-Current Debt came in at $450,000 for Q3 2021, unchanged from the prior quarter.

Analysis

Skye Bioscience (SKYE) Net Long-Term Debt Issued (Repaid) (2013 - 2026) Analysis & Trends

Going back to Q2 2013, Skye Bioscience's Non-Current Debt data covers 5 quarters.

  • Business Quant data shows SKYE's Non-Current Debt at $450,000 (Q2 2021), $450,000 (Q1 2021) and $450,000 (Q4 2020) in the three quarters before Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn -1.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 9.98 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 4.91 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Skye Bioscience 5.38 Mn -52.34 Mn - -107,287.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -107,287.00
Jun 30, 2026 -107,288.00
Mar 31, 2026 -71,525.00
Dec 31, 2024 83.56 Mn
Dec 31, 2023 6.76 Mn
Mar 31, 2018 400,000.00
Oct 31, 2013 -4,423.00
Jan 31, 2013 32,000.00
API Access

Skye Bioscience Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=SKYE&period=max&api_key=YOUR_API_KEY